Taiichi Saito Selected Research

Taiichi Saito Research Topics

26	Neoplasms (Cancer) 01/2023 - 06/2005
19	Glioma (Gliomas) 08/2023 - 01/2007
17	Glioblastoma (Glioblastoma Multiforme) 08/2023 - 06/2005
10	Brain Neoplasms (Brain Tumor) 01/2023 - 06/2005
5	Astrocytoma (Pilocytic Astrocytoma) 06/2017 - 05/2006
3	Oligodendroglioma 06/2017 - 07/2008
2	Exanthema (Rash) 01/2022 - 10/2013
2	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 06/2017 - 08/2008
2	Pinealoma (Pineoblastoma) 06/2017 - 07/2008
2	Ependymoma 06/2017 - 06/2005
2	Primitive Neuroectodermal Tumors (PNET) 06/2017 - 06/2005
1	Giant Cell Tumor of Bone 02/2022
1	Residual Neoplasm 02/2022
1	Osteosclerosis 02/2022
1	Drug Hypersensitivity (Drug Allergy) 01/2022
1	Neutropenia 04/2018
1	Breast Neoplasms (Breast Cancer) 10/2017
1	Medulloblastoma 06/2017
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 06/2017
1	Cysts 06/2015
1	Hemorrhage 06/2015
1	Brain Abscess (Abscess, Brain) 01/2015
1	Aneuploidy (Aneuploid) 01/2015
1	Vomiting 01/2014
1	Nausea 01/2014
1	Constipation 01/2014
1	Erythema 10/2013
1	Blister (Bulla) 10/2013
1	Diffuse Intrinsic Pontine Glioma 07/2011
1	Meningioma (Meningiomas) 07/2008
1	Retinoblastoma (Glioblastoma, Retinal) 01/2007
1	Genomic Instability 01/2007
1	Lymphoma (Lymphomas) 06/2005

5	Temozolomide (Temodar)FDA LinkGeneric 12/2020 - 01/2017
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2022 - 10/2013
3	Talaporfin (talaporfin sodium)IBA 02/2022 - 10/2013
3	SurvivinIBA 01/2018 - 04/2007
2	Biomarkers (Surrogate Marker)IBA 08/2023 - 03/2010
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 07/2018 - 06/2018
2	Indicators and Reagents (Reagents)IBA 07/2016 - 05/2006
2	GadoliniumIBA 01/2015 - 08/2008
2	Lactic Acid (Lactate)FDA LinkGeneric 07/2011 - 10/2005
2	2,6-dinitrotoluene (DNT)IBA 08/2008 - 06/2005
1	VimentinIBA 08/2023
1	Formaldehyde (Formol)FDA Link 01/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2023
1	Cancer VaccinesIBA 01/2023
1	ParaffinIBA 01/2023
1	Denosumab FDA Link 02/2022
1	Lacosamide FDA Link 01/2022
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2022
1	Aligeron (AS 2)IBA 12/2019
1	Bevacizumab (Avastin)FDA Link 06/2018
1	Messenger RNA (mRNA)IBA 10/2017
1	GlypicansIBA 09/2017
1	Capsules (Microcapsules)IBA 06/2015
1	AntiemeticsIBA 01/2014
1	Granisetron (Kytril)FDA LinkGeneric 01/2014
1	PhosphoproteinsIBA 12/2010
1	ElementsIBA 08/2008
1	GemininIBA 03/2007
1	DNA (Deoxyribonucleic Acid)IBA 03/2007
1	Retinoblastoma ProteinIBA 01/2007
1	StaurosporineIBA 01/2007
1	ErbB Receptors (EGF Receptor)IBA 03/2006
1	LipidsIBA 10/2005

11	Radiotherapy 01/2023 - 01/2014
10	Craniotomy 01/2023 - 10/2014
6	Drug Therapy (Chemotherapy) 01/2023 - 03/2006
6	Therapeutics 02/2022 - 08/2008
5	Photochemotherapy (Photodynamic Therapy) 01/2023 - 10/2013
2	Chemoradiotherapy 01/2023 - 09/2017
2	Electrodes (Electrode) 01/2022 - 01/2015
2	Semiconductor Lasers 12/2018 - 10/2013
2	Cranial Irradiation 06/2017 - 07/2008
2	Craniospinal Irradiation 06/2017 - 01/2014
1	Curettage 02/2022
1	Operating Tables 02/2022
1	General Anesthesia 01/2022
1	Lasers (Laser) 12/2018
1	Intravenous Injections 10/2013